Vita Life Sciences Limited (VLS.AX)
AUD 1.75
(-3.58%)
AUD 1.75
(-3.58%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 12.21 Million AUD | 13.4% |
| 2022 | 10.77 Million AUD | -4.72% |
| 2021 | 11.3 Million AUD | 35.82% |
| 2020 | 8.32 Million AUD | 81.99% |
| 2019 | 4.57 Million AUD | 3.27% |
| 2018 | 4.42 Million AUD | -7.96% |
| 2017 | 4.81 Million AUD | -17.11% |
| 2016 | 5.8 Million AUD | -7.27% |
| 2015 | 6.26 Million AUD | -11.32% |
| 2014 | 7.05 Million AUD | 24.89% |
| 2013 | 5.65 Million AUD | 88.9% |
| 2012 | 2.99 Million AUD | 89.36% |
| 2011 | 1.58 Million AUD | -67.59% |
| 2010 | 4.87 Million AUD | 3242.77% |
| 2009 | -155.11 Thousand AUD | -131.69% |
| 2008 | 489.45 Thousand AUD | 335.91% |
| 2007 | 112.28 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 5.89 Million AUD | 0.0% |
| 2023 Q2 | 5.49 Million AUD | 0.0% |
| 2023 Q4 | 6.71 Million AUD | 0.0% |
| 2023 FY | 12.21 Million AUD | 13.4% |
| 2022 Q2 | 5.52 Million AUD | 0.0% |
| 2022 Q4 | 5.5 Million AUD | 0.0% |
| 2022 FY | 10.77 Million AUD | -4.72% |
| 2021 Q4 | 6.32 Million AUD | 0.0% |
| 2021 FY | 11.3 Million AUD | 35.82% |
| 2021 Q2 | 4.94 Million AUD | 0.0% |
| 2020 Q2 | 4.05 Million AUD | 0.0% |
| 2020 Q4 | 3.48 Million AUD | 0.0% |
| 2020 FY | 8.32 Million AUD | 81.99% |
| 2019 FY | 4.57 Million AUD | 3.27% |
| 2019 Q4 | 2.85 Million AUD | 0.0% |
| 2019 Q2 | 1.25 Million AUD | 0.0% |
| 2018 Q2 | 2.76 Million AUD | 147.35% |
| 2018 Q1 | 1.11 Million AUD | -52.07% |
| 2018 Q4 | 3.31 Million AUD | 0.0% |
| 2018 FY | 4.42 Million AUD | -7.96% |
| 2017 Q4 | 2.32 Million AUD | 0.0% |
| 2017 Q1 | 1.2 Million AUD | -55.02% |
| 2017 FY | 4.81 Million AUD | -17.11% |
| 2017 Q2 | 2.36 Million AUD | 96.51% |
| 2016 Q2 | 2.97 Million AUD | 104.79% |
| 2016 Q1 | 1.45 Million AUD | -60.95% |
| 2016 FY | 5.8 Million AUD | -7.27% |
| 2016 Q4 | 2.67 Million AUD | 0.0% |
| 2015 Q4 | 3.71 Million AUD | 136.28% |
| 2015 FY | 6.26 Million AUD | -11.32% |
| 2015 Q2 | 2.37 Million AUD | 50.95% |
| 2015 Q1 | 1.57 Million AUD | -55.7% |
| 2015 Q3 | 1.57 Million AUD | -33.75% |
| 2014 Q3 | 1.76 Million AUD | -46.87% |
| 2014 Q2 | 3.31 Million AUD | 88.2% |
| 2014 Q1 | 1.76 Million AUD | -42.93% |
| 2014 FY | 7.05 Million AUD | 24.89% |
| 2014 Q4 | 3.55 Million AUD | 101.53% |
| 2013 Q1 | 1.4 Million AUD | 0.0% |
| 2013 Q4 | 3.08 Million AUD | 119.16% |
| 2013 Q3 | 1.4 Million AUD | -44.7% |
| 2013 Q2 | 2.54 Million AUD | 80.84% |
| 2013 FY | 5.65 Million AUD | 88.9% |
| 2012 Q1 | 757.25 Thousand AUD | 0.0% |
| 2012 Q2 | 757.25 Thousand AUD | 0.0% |
| 2012 Q3 | 757.25 Thousand AUD | 0.0% |
| 2012 Q4 | 1.4 Million AUD | 86.13% |
| 2012 FY | 2.99 Million AUD | 89.36% |
| 2011 Q2 | 390.13 Thousand AUD | 0.0% |
| 2011 Q4 | 757.25 Thousand AUD | 94.1% |
| 2011 FY | 1.58 Million AUD | -67.59% |
| 2011 Q1 | 390.13 Thousand AUD | 0.0% |
| 2011 Q3 | 390.13 Thousand AUD | 0.0% |
| 2010 FY | 4.87 Million AUD | 3242.77% |
| 2010 Q4 | 390.13 Thousand AUD | -67.7% |
| 2010 Q3 | 1.2 Million AUD | 0.0% |
| 2010 Q2 | 1.2 Million AUD | 0.0% |
| 2010 Q1 | 1.2 Million AUD | 0.0% |
| 2009 Q2 | -39.57 Thousand AUD | 0.0% |
| 2009 FY | -155.11 Thousand AUD | -131.69% |
| 2009 Q4 | 1.2 Million AUD | 3152.07% |
| 2009 Q3 | -39.57 Thousand AUD | 0.0% |
| 2009 Q1 | -39.57 Thousand AUD | 0.0% |
| 2008 Q2 | 107.99 Thousand AUD | 0.0% |
| 2008 Q4 | -39.57 Thousand AUD | -136.64% |
| 2008 Q1 | 107.99 Thousand AUD | 0.0% |
| 2008 FY | 489.45 Thousand AUD | 335.91% |
| 2008 Q3 | 107.99 Thousand AUD | 0.0% |
| 2007 Q4 | 107.99 Thousand AUD | 2281.44% |
| 2007 FY | 112.28 Thousand AUD | 0.0% |
| 2007 Q3 | -4950.50 AUD | 0.0% |
| 2007 Q1 | -4950.50 AUD | 0.0% |
| 2007 Q2 | -4950.50 AUD | 0.0% |
| 2006 Q4 | -4950.50 AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Althea Group Holdings Limited | -11.69 Million AUD | 204.42% |
| Cann Group Limited | -13.47 Million AUD | 190.622% |
| ECS Botanics Holdings Ltd | 1.43 Million AUD | -749.06% |
| Ecofibre Limited | -15.02 Million AUD | 181.287% |
| Elixinol Wellness Limited | -5.99 Million AUD | 303.923% |
| Hygrovest Limited | -1.1 Million AUD | 1207.434% |
| IDT Australia Limited | -4.94 Million AUD | 346.818% |
| Invion Limited | -7.55 Million AUD | 261.741% |
| Little Green Pharma Ltd | -7.62 Million AUD | 260.138% |
| Live Verdure Ltd | -12.54 Million AUD | 197.407% |
| Medical Developments International Limited | -16.86 Million AUD | 172.42% |
| Vitura Health Limited | 4.86 Million AUD | -150.969% |